Clinical TrialID 7132
Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
NCT03824327
Lung Non-Small Cell Carcinoma
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7132
- Evidence Id
- 7132
- Core Evidence Id
- 7132
- Source Clinical Trial Id
- 7122
- Herb2 Clinical Trial Id
- HBCT007122
- Nct Id
- NCT03824327
- Title
- Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
- Status
- Suspended
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Lung Non-Small Cell Carcinoma
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- PROCEDURE: Blood Oxygen Level Dependent Imaging|DRUG: Papaverine Hydrochloride|RADIATION: Stereotactic Body Radiation Therapy
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 24
- Outcome Measure
- Maximum-tolerated dose (MTD), Will employ the Bayesian optimal interval (BOIN) design to find the MTD., Up to 2 weeks
- Sponsor Collaborator
- Ohio State University Comprehensive Cancer Center
- Funded By
- OTHER
- Location
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States
- Other Id
- OSU-18215|NCI-2019-00105
- Start Date
- 2019-02-07
- Primary Completion Date
- 2024-12-31
- Completion Date
- 2024-12-31
- First Posted
- 2019-01-31
- Results First Posted
- Last Update Posted
- 2023-11-24
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03824327
- Title Cn
- Title En
- Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
- Bilingual Status
- semi_complete